Vikas Gupta

Vikas assumed the role of President at ReciBioPharm, the biologics business unit of Recipharm, in May 2023. Since taking charge, he has dedicated his efforts to fostering excellence, with a particular emphasis on advancing xRNA manufacturing, plasmid DNA, viral vector, live virus and microbiome live therapeutics within the division. With over two decades of experience in the life science industry, Vikas has held various senior positions in pharma and bioprocessing companies such as Repligen, GE Healthcare, Merck Millipore and Bayer. His extensive background encompasses roles in general management, commercial operations, product management, corporate finance, business strategy, and mergers and acquisitions.

‍